Q32 Bio (QTTB) Shareholder's Equity (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 46.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.31 Mn |
| Dec 31, 2025 | 42.01 Mn |
| Sep 30, 2025 | -18.45 Mn |
| Jun 30, 2025 | -12.24 Mn |
| Mar 31, 2025 | -4.01 Mn |
| Dec 31, 2024 | 5.68 Mn |
| Sep 30, 2024 | 18.30 Mn |
| Jun 30, 2024 | 33.51 Mn |
| Mar 31, 2024 | 48.77 Mn |
| Dec 31, 2023 | -182.92 Mn |
| Sep 30, 2023 | -156.45 Mn |
| Jun 30, 2023 | -142.72 Mn |
| Mar 31, 2023 | -137.24 Mn |
| Dec 31, 2022 | -130.71 Mn |
| Sep 30, 2022 | 209.06 Mn |
| Jun 30, 2022 | 240.29 Mn |
| Mar 31, 2022 | 266.25 Mn |
| Dec 31, 2021 | 169.65 Mn |
| Sep 30, 2021 | 198.57 Mn |
| Jun 30, 2021 | 224.58 Mn |
| Mar 31, 2021 | 200.83 Mn |
| Dec 31, 2020 | 196.00 Mn |
| Sep 30, 2020 | 170.22 Mn |
| Jun 30, 2020 | 194.70 Mn |
| Mar 31, 2020 | 226.54 Mn |
| Dec 31, 2019 | 258.51 Mn |
| Sep 30, 2019 | 257.82 Mn |
| Jun 30, 2019 | 284.74 Mn |
| Mar 31, 2019 | 174.26 Mn |
| Dec 31, 2018 | 196.36 Mn |
| Sep 30, 2018 | 214.18 Mn |
| Jun 30, 2018 | 227.57 Mn |
| Mar 31, 2018 | -49.22 Mn |
| Dec 31, 2017 | -39.45 Mn |